It was reassuring to hear directly from Steven, during QnA on todays Reachmarket's webinar, he intends to convert his 3,500,000 options due for expiry 2nd May 2023.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
